Keyphrases
Scotland
100%
Antibiotic Prescribing
73%
Antimicrobial Use
70%
Clostridium Difficile Infection
70%
Primary Care
65%
Care Homes
65%
Antibiotics
54%
Antimicrobial
53%
Sepsis
50%
Interrupted Time Series
49%
Antimicrobial Stewardship Program
44%
Antibiotic Use
42%
Antimicrobial Resistance
41%
Care Home Residents
39%
Tayside
39%
Acute Kidney Injury
36%
Confidence Interval
34%
Community-acquired Pneumonia
32%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
30%
Methicillin-resistant Staphylococcus Aureus
30%
Bloodstream Infection
30%
Flucloxacillin
28%
High Risk
28%
Scottish
27%
Gentamicin
27%
General Practice
27%
Hospital Inpatients
26%
Orthopedic Surgery
25%
Antibiotic Prescription
25%
Antimicrobial Stewardship
24%
Administrative Data
24%
Clinical Outcomes
24%
Staphylococcus Aureus
23%
Randomized Controlled Trial
23%
Comorbidity
22%
Soft Tissue Infection
22%
Skin Tissue
22%
Patient Outcomes
22%
Cephalosporins
22%
Prescribing Practices
21%
Older Patients
21%
Segmented Regression
21%
NHS Scotland
21%
Population-based
21%
Older People
21%
Postoperative Acute Kidney Injury
21%
Blood Culture
20%
Severity Assessment
20%
Microbiology
20%
Sepsis Management
20%
Medicine and Dentistry
Antiinfective Agent
90%
Infection
80%
Sepsis
76%
Primary Health Care
63%
Antibiotics
60%
Time Series Analysis
52%
Cohort Analysis
50%
Antibiotic Resistance
44%
Randomized Controlled Trial
44%
General Medicine
41%
Comorbidity
38%
Cohort Effect
35%
Bloodstream Infection
31%
Hospital-Acquired Pneumonia
30%
Nonsteroid Antiinflammatory Agent
30%
Systematic Review
28%
Soft Tissue Infection
24%
Clostridium Difficile Infection
24%
Intensive Care
21%
Kidney Function
21%
Eczema
20%
Cohort Study
20%
COVID-19
20%
Hospital Inpatient
19%
Orthopedics
17%
Logistic Regression Analysis
16%
Placebo
16%
Acute Kidney Injury
15%
Quality Improvement
15%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
14%
Blood Culture
14%
Antimicrobial Therapy
14%
Staphylococcus Aureus
14%
Meta-Analysis
13%
Antibiotic Therapy
12%
Meticillin
11%
Community-Acquired Pneumonia
11%
Prospective Study
11%
Health Service
11%
Amoxicillin Plus Clavulanic Acid
10%
Population Research
10%
Respiratory Tract Infection
10%
Lung Infection
10%
Retrospective Cohort Study
10%
Health Care Cost
10%
Community Acquired Infection
10%
Patient Satisfaction
10%
Health Informatics
10%
Bronchodilating Agent
10%
Carbapenem
10%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
91%
Antibiotics
70%
Infection
66%
Clostridium Difficile Infection
52%
Cohort Study
50%
Randomized Controlled Trial
49%
Acute Kidney Failure
45%
Bloodstream Infection
36%
Comorbidity
33%
Sepsis
30%
Methicillin-Resistant Staphylococcus Aureus
30%
Staphylococcus Aureus
29%
Antimicrobial Resistance
29%
Meticillin
27%
Gentamicin
26%
Flucloxacillin
25%
Case-Control Study
21%
Soft Tissue Infection
21%
Cephalosporin Derivative
20%
Hospital Acquired Pneumonia
20%
Observational Study
20%
Antibiotic Prophylaxis
19%
Quinolone Derivative
17%
Trimethoprim
16%
Diseases
15%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
14%
Antimicrobial Therapy
14%
Antidepressant
14%
Amoxicillin Plus Clavulanic Acid
14%
Infectious Agent
13%
Nitrofurantoin
11%
Surgical Prophylaxis
11%
Prospective Study
11%
Population Study
10%
Respiratory Tract Infection
10%
Lung Infection
10%
Cross-Sectional Study
10%
Zidebactam
10%
Cefepime
10%
Polypharmacy
10%
Cholinergic Receptor Blocking Agent
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Psychotropic Agent
10%
Community Acquired Pneumonia
10%
Carbapenemase
10%
Prospective Cohort Study
10%
Eczema
10%
Enterobacteriaceae
10%
Bacterial Endocarditis
10%
Carbapenem
10%
